Pfizer Liabilities 2024

Pfizer Aktienanalyse

What does Pfizer do?

Pfizer Inc, one of the world's largest and most well-known pharmaceutical companies, has made significant advancements in the medical industry throughout its approximately 170-year history. The company is headquartered in New York City and has offices in over 150 countries. Pfizer was founded in 1849 by two cousins, Charles Pfizer and Charles Erhart, who opened their first factory in Brooklyn to produce pure crystalline chinasalt. They later expanded their business and began synthesizing chemical compounds, leading them to enter the pharmaceutical industry. In the following years, Pfizer made some significant discoveries, including the synthesis of antibiotics such as penicillin and terramycin. In the 1990s, the company expanded its portfolio and became a leading provider of prescription drugs, immunological medications, and animal health products. Today, the company focuses on three core areas: innovative health products, patented medications, and generic products. Pfizer invests millions of dollars in research and development of new and innovative treatment options, including cancer drugs, therapies for neurological disorders, cardiovascular diseases, and immunology products. Another important aspect of Pfizer's business model is its partnerships with other companies and organizations. The company works closely with universities, research institutions, governments, and other companies to form partnerships that allow for collaborative development of new products. Some of Pfizer's most well-known products include Viagra, Lipitor, Celebrex, Zoloft, and Lyrica. Viagra is used to treat erectile dysfunction in men. Lipitor is a cholesterol-lowering medication that reduces the risk of cardiovascular diseases. Celebrex is an anti-inflammatory medication used to treat pain and inflammation. Zoloft is an antidepressant used to treat various mental disorders. Lyrica is a prescription medication used to treat pain and seizures. In recent years, Pfizer has also taken a leading role in the development of vaccines against COVID-19, collaborating with the German company BioNTech to develop a promising vaccine candidate. The vaccine provides protection against the virus, particularly against severe illness. Over the years, the company has faced concerns regarding the use of medications, such as the scandal surrounding the pain reliever Vioxx, which was withdrawn in 2004 after being associated with an increased risk of cardiovascular diseases. Pfizer has since strengthened its research and development standards and partnerships to ensure the safety and efficacy of its products. In summary, Pfizer is a global player in the pharmaceutical industry. The company heavily invests in research and development of new products to provide innovative treatment options, secures patents, and simultaneously keeps its portfolio up-to-date with generic products to remain competitive in the industry. The company will continue to contribute to improving healthcare worldwide by developing lifesaving medications and vaccines that enable people to lead better lives. Pfizer ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Pfizer's Liabilities

Pfizer's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Pfizer's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Pfizer's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Pfizer's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Pfizer’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Pfizer Stock

What is the level of liabilities of Pfizer this year?

Pfizer has a debt balance of 137.49 B USD this year.

What were the liabilities of Pfizer compared to the previous year?

The liabilities of Pfizer have increased by 35.4% increased compared to the previous year.

What are the consequences of high debt for investors of Pfizer?

High liabilities can pose a risk for investors of Pfizer, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Pfizer?

Low liabilities mean that Pfizer has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Pfizer affect the company?

An increase in liabilities of Pfizer can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Pfizer affect the company?

A decrease in the liabilities of Pfizer can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Pfizer?

Some factors that can influence the liabilities of Pfizer include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Pfizer so important for investors?

The liabilities of Pfizer are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Pfizer take to modify the liabilities?

To change its liabilities, Pfizer can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Pfizer pay?

Over the past 12 months, Pfizer paid a dividend of 2.05 USD . This corresponds to a dividend yield of about 7.8 %. For the coming 12 months, Pfizer is expected to pay a dividend of 2.45 USD.

What is the dividend yield of Pfizer?

The current dividend yield of Pfizer is 7.8 %.

When does Pfizer pay dividends?

Pfizer pays a quarterly dividend. This is distributed in the months of August, December, December, February.

How secure is the dividend of Pfizer?

Pfizer paid dividends every year for the past 26 years.

What is the dividend of Pfizer?

For the upcoming 12 months, dividends amounting to 2.45 USD are expected. This corresponds to a dividend yield of 9.31 %.

In which sector is Pfizer located?

Pfizer is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pfizer kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pfizer from 3/1/2024 amounting to 0.42 USD, you needed to have the stock in your portfolio before the ex-date on 1/25/2024.

When did Pfizer pay the last dividend?

The last dividend was paid out on 3/1/2024.

What was the dividend of Pfizer in the year 2023?

In the year 2023, Pfizer distributed 1.6 USD as dividends.

In which currency does Pfizer pay out the dividend?

The dividends of Pfizer are distributed in USD.